ESGO – 2022 |Efficacy and safety of VB10.16, therapeutic DNA vaccine specifically targeting antigen presenting cells, in combination with atezolizumab in patients with advanced HPV16-positive cervical cancer: results from a pre-planned interim analysis
Download (24MB) Warning: Undefined array key "HTTP_REFERER" in /var/www/0/351003/www/wp-content/themes/nykode-understrap-child/loop-templates/content-single-scientific.php on line 64
